You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Cell Dev. Biol., 04 June 2024

Sec. Signaling

Volume 12 - 2024 | https://doi.org/10.3389/fcell.2024.1416720

Corrigendum: Dysregulation of BMP, Wnt, and insulin signaling in fragile X syndrome

  • 1. Department of Biological Sciences, College of Arts and Science, Vanderbilt University, Nashville, TN, United States

  • 2. Department of Cell and Developmental Biology, School of Medicine, Vanderbilt University, Nashville, TN, United States

  • 3. Kennedy Center for Research on Human Development, Nashville, TN, United States

  • 4. Vanderbilt Brain Institute, School of Medicine, Vanderbilt University and Medical Center, Nashville, TN, United States

Article metrics

View details

1

Citations

828

Views

372

Downloads

In the published article, there was an error in the legend of Figure 2 as published. The expression level of glial Draper with loss of neuronal FMRP was mistakenly summarized. Based on the conclusion of our reviewed paper, loss of neuronal FMRP should decrease the expression level of glial Draper. The corrected Figure 2 legend appears below:

Figure 2 | Secreted signals regulated by neuronal FMRP orchestrate glial phagocytosis. In early adult Drosophila brain PDF-Tri neurons, FMRP is proposed to promote the secretion of insulin-like peptides (ILPs) that drive glial insulin receptor phosphorylation (InR-P) to trigger glial phagocytosis of neuronal processes. In the glia, Draper (Drpr) phagocytosis receptor expression is decreased by loss of neuronal FMRP. However, the neuronal Drpr ligands (for example, Pretaporter, phosphatidylserine) involved in this FMRP-dependent mechanism remain unknown. Neuronal FMRP may regulate numerous other “find me” and “eat me” secreted neural signals that recruit glia and instruct glial phagocytosis, ranging from individual synapses to whole brain neurons.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

bone morphogenetic protein, insulin-like peptide, fragile x mental retardation protein, wingless, Drosophila

Citation

Song C and Broadie K (2024) Corrigendum: Dysregulation of BMP, Wnt, and insulin signaling in fragile X syndrome. Front. Cell Dev. Biol. 12:1416720. doi: 10.3389/fcell.2024.1416720

Received

13 April 2024

Accepted

14 May 2024

Published

04 June 2024

Volume

12 - 2024

Edited and reviewed by

Brian Storrie, University of Arkansas for Medical Sciences, United States

Updates

Copyright

*Correspondence: Kendal Broadie,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics